2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
28
Genitourinary
13
Breast
12
Thoracic
8
Other solid neoplasm
8
Dermatologic
5
Sarcoma
4
Plasma cell
4
Other hematologic neoplasm
4
Tumor-Agnostic
3
Gynecologic
3
CNS
3
Myeloid
2
Lymphoid
2
Other
1
Head & Neck
1
Conditions
Radiation-induced Oral Mucositis
1
Interventions
Exercise
28
Metformin
24
Surveys and Questionnaires
19
Radiotherapy
14
Methods
14
Early Intervention, Educational
13
Counseling
13
Educational Status
12
naloxegol
10
Standard of Care
10
Tirzepatide
9
Nutrition Assessment
9
Diet Therapy
9
Cisplatin
9
Resistance Training
8
Psychiatric Rehabilitation
8
Diet
8
Therapeutics
7
Interviews as Topic
7
alvimopan
6
Liraglutide
6
Fibroblast Growth Factor 7
6
Caloric Restriction
6
semaglutide
5
Radiation
5
Low-Level Light Therapy
5
Injections
5
Exenatide
5
Diet, Mediterranean
5
Dexamethasone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hydroxychloroquine
×
Other
×
Clear all
NCT06939582
2025-04-29
RIOM
West China Hospital
Phase 1/2
Recruiting
158 enrolled